Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Anthony Shuber, Greg Lucier, Craig Tuttle

Premium

Nabsys said that Anthony Shuber has joined the company as vice president and chief scientific officer. He comes to Nabsys from Ignyta, an oncology precision medicine firm, where he served as chief technology officer. Prior to joining Ignyta, Shuber was co-founder and CTO of Predictive Biosciences, and scientific co-founder of Exact Sciences. He also previously worked for Genzyme Genetics/Integrated Genetics and Genetics Institute.


Former Life Technologies CEO and chairman Greg Lucier has joined the board of directors at Invuity, a medical device company based in San Francisco. Prior to Life Tech, Lucier held senior management positions at General Electric, most recently CEO and president of Medical Systems Information Technologies for GE Healthcare. He holds an MBA from Harvard Business School and a BS in industrial engineering from Pennsylvania State University.


Former Transgenomic President and CEO Craig Tuttle was named president of private investment firm Prairie Ventures. Tuttle was also the president of Duke Scientific, which he sold to Fisher Scientific, now part of Thermo Fisher Scientific, and was president of Applied Biotech and Seradyn within the Apogent group, now also Thermo Fisher.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.